🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for TNBC is out in Molecular Cancer Therapeutics today. Congrats to all the coauthors! And of course a lot more to be explored in the future. Kornelia Polyak aacrjournals.org/mct/article/do…

Congrats Nelly for receiving the 2023 #AACR Distinguished Lectureship in Breast Cancer Research Award! We take immense pride in this remarkable achievement, and we remain dedicated to our ongoing efforts in the fight against breast cancer.

Our resource paper on TNBC omic is officially out in Cell Reports. We dissected TNBC heterogeneity with deep multiomic profiling on 34 TNBC cell lines and identified drivers of TNBC classification. Congrats to all! Kornelia Polyak sciencedirect.com/science/articl…

We are thrilled to announce that Nelly has been elected as a member of the prestigious American Academy of Arts and Sciences. Congratulations! We're so very proud of you!@nellage Dana-Farber Dana-Farber News

Our study characterizing breast cancer brain metastasis is officially out in PNASNews. We reproted breast cancer-stromal cells interaction induces resistance to HER2-targeting agents via bulky glycoproteins. Congrats to @MarieAnneGoyet1 and Kornelia Polyak. pnas.org/doi/abs/10.107…

Thrilled to share that my aging and breast cancer paper is now published in Cancer Cell! 🎉 In this study, we identified “Midkine” as a key factor linking aging with cancer. Polyak Lab Check it out! #CancerResearch #BreastCancer #Aging cell.com/cancer-cell/fu…

🎃Polyak lab is getting ready for the MCO halloween pumpkin decoration contest! Huge shoutout to @MarieAnneGoyet1 and Andriana who made this piece of work based on the lab logo! Science and creativity go hand in hand!

We are thrilled to see our study about ZBTB7A in basal breast cancer is out in Cell Reports . We identified ZBTB7A as an novel interactor and regulator of KDM5 using CRISPR screen, and characterized its functional impact on NFkB pathway. Congrats to all!